Alogliptin and pioglitazone

DRUG4 trials

Sponsors

Takeda

Conditions

Diabetes MellitusType 2 Diabetes Mellitus

Phase 2

Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

CompletedNCT01318070

TakedaType 2 Diabetes Mellitus

Start: 2007-11-30End: 2008-10-31Updated: 2012-02-03

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

CompletedNCT01318122

TakedaType 2 Diabetes Mellitus

Start: 2008-05-31End: 2009-08-31Updated: 2012-02-03

Phase 3

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

CompletedNCT00286494

TakedaDiabetes Mellitus

Start: 2006-02-28End: 2007-08-31Updated: 2012-02-03

Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

CompletedNCT00655863

TakedaDiabetes Mellitus

Start: 2007-07-31End: 2009-12-31Updated: 2013-05-27

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

2012-01-1270 citations

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

2009-10-01102 citations